However, BRCA1/2 mutations constitute but a small part of breast cancers, approximately 25% of patients with TNBC, which itself is said to constitute about 15% of all breast cancers presented (Barchiesi et al., 2021). The gene discussed is BRCA1; the disease is breast carcinoma.